ETV 24/7 BreakingNewsShow : Cliccate nantu à u buttone di volumu (in basso à sinistra di u schermu video)
Cliccate quì s'ellu hè u vostru comunicatu di stampa!

Medicamentu di pressione alta di Losartan avà ricurdatu

scrittu da santu Orsuvè

Mint Pharmaceuticals Inc. hà ricurdatu tutti i lotti di i so pasticchi di losartan di prescrizione, in forze di 50 mg è 100 mg, dopu chì e teste anu truvatu una impurità azido (5-(4′-((5-(azidometil)-2-butil-4-chloro). -1H imidazol-1-il)metil)-[1,1′-bifenil]-2-il)-1H tetrazole) sopra u limitu accettabile. L'esposizione à longu andà à l'impurità à livelli sopra à ciò chì hè cunsideratu sicuru puderia aumentà u risicu di cancru.

Print Friendly, PDF è Email

Per piacè vede u cunsigliu cumpletu per più infurmazione, cumpresu ciò chì i Canadiani duveranu fà è u travagliu di Health Canada per affruntà u prublema di impurità azido truvate in certi droghe.

pruduttuSicíliaDINLotStimusu
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005011154June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896572005011156June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg COMPRESSEMint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg COMPRESSE Mint Pharmaceuticals Inc.023896652105002149December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896731805012687October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896731805012688October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896731805012689October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896731805012792October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896731905001010December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSE Mint Pharmaceuticals Inc.023896731905001011December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSE Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732005013776August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg COMPRESSEMint Pharmaceuticals Inc.023896732105002150December 2023
Print Friendly, PDF è Email

Doppu l'autore

Orsuvè

Redattore in capu hè Linda Hohnholz.

Lascia un Comment